Understanding Family Decision Making about Starting Ustekinumab (Stelara)

Purpose: The purpose of this study is to evaluate the decision-making experience of families choosing treatment with ustekinumab for their children with IBD.

Study Period: March 2021-February 2022

Contact: Ellen Lipstein

if page.is_commentable? include "comments" endif

Join our CIRCLE community.

We're social!

Follow us to get the latest.

Tools For Living With IBD
Get Involved

Stay in the LOOP

Updates from the ICN Blog

Fiber and IBD

Posted August 15

You are not alone if you have less common IBD symptoms or locations of inflammation

Posted August 01

ICN Research Explained: High body mass index and response to anti-tumor necrosis factor therapy in pediatric Crohn’s disease

Posted June 26

See All Posts

Built by Veracity Media on NationBuilder